Certain immune cells acquired from a coronavirus that causes the common cold appear to react to COVID – but more so in children that adults.

A handful of animals make a pared-down version of these pathogen-fighting proteins of our immune system. Scientists hope to harness them as treatments for ills from cancer to Covid, for tracking cells in the body, and more.

Two new studies have suggested that existing diabetes and antiviral drugs could be repurposed to prevent symptoms of COVID-19.

From building up defenses in the nose to slowing down a virus’s ability to make copies of itself, scientists are rolling out a raft of creative approaches to fighting infection.

Resilience can look like a canny financial strategy or a health worker crawling up a rickety ladder, finds John Agaba in Kampala.

Researchers welcome new WHO malaria guidelines but urge vigilance against resistance.

Progress in many areas of TB control stalled or reversed mainly because of the COVID-19 pandemic and the recent geo-political situations.

User fees is a major barrier to healthcare, including maternal and newborn care in Kenya.

As the latest IPCC report on how climate change is affecting the world shows, the consequences of a rapidly warming earth are devastating to human health. We need urgent action

First on their to-do list? Build out the cold chain.

Village health workers, like Mugano, have been instrumental in delivering health services to people in hard-to-reach areas and ensuring that no one is left behind.

While they wait for the vaccine, residents of this Lagos enclave are taking the fight to the malarial messengers.